• 21 Citations
20162023

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

My primary goal is to provide compassionate, evidence-based care to people with lung diseases or in the ICU. I am a board-certified pulmonologist and intensivist and have sub-specialty interests in cystic fibrosis, bronchiectasis, and lung transplant. During my fellowship, I acquired experience in laboratory science under Jing Liu, PhD, and firmly believe advancement of excellent medicine is only possible through scientific research. To that end, I spend a portion of my time committed to research of lung disease biology.

I am interested in using cells from the nose (nasal epithelium) to study an array of lung diseases, including cystic fibrosis, COPD, bronchiectasis, and interstitial lung diseases. In the future, this could ideally provide a more accessible, less risky alternative to lung biopsy.

I specialize in critical care medicine, cystic fibrosis, lung transplantation, and bronchiectasis.

Training Experience

2012Residency, Medical College of Wisconsin
2013Residency, Medical College of Wisconsin
2016Fellowship, Northwestern University, McGaw Medical Center

Education/Academic qualification

MD, Northwestern University Feinberg School of Medicine

… → 2009

Research interests

  • Cystic Fibrosis
  • Transplantation

Fingerprint Dive into the research topics where Marc A Sala is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Research Output

  • 21 Citations
  • 6 Article
Open Access
  • A young man with fevers and an invasive mediastinal mass

    Sala, M. A., Celli, D., Yeldandi, A., Gillespie, C. T. & Argento, A. C., Dec 2018, In : Annals of the American Thoracic Society. 15, 12, p. 1477-1482 6 p.

    Research output: Contribution to journalArticle

    Inflammatory pathways are upregulated in the nasal epithelium in patients with idiopathic pulmonary fibrosis

    Sala, M. A., Balderas-Martínez, Y. I., Buendía-Roldan, I., Abdala-Valencia, H., Nam, K., Jain, M., Bhorade, S., Bharat, A., Reyfman, P. A., Ridge, K. M., Pardo, A., Sznajder, J. I., Budinger, G. R. S., Misharin, A. V. & Selman, M., Nov 26 2018, In : Respiratory Research. 19, 1, 233.

    Research output: Contribution to journalArticle

  • JNK2 up-regulates hypoxia-inducible factors and contributes to hypoxia-induced erythropoiesis and pulmonary hypertension

    Sala, M. A., Chen, C., Zhang, Q., Do-Umehara, H. C., Wu, W., Misharin, A. V., Waypa, G. B., Fang, D., Budinger, G. R. S., Liu, S., Chandel, N. S., Schumacker, P. T., Sznajder, J. I. & Liu, J., Jan 1 2018, In : Journal of Biological Chemistry. 293, 1, p. 271-284 14 p.

    Research output: Contribution to journalArticle

  • 5 Scopus citations

    Tezacaftor for the treatment of cystic fibrosis

    Sala, M. A. & Jain, M., Sep 2 2018, In : Expert Review of Respiratory Medicine. 12, 9, p. 725-732 8 p.

    Research output: Contribution to journalArticle

  • 12 Scopus citations